Global Pentavalent Vaccine Supply, Demand and Key Producers, 2023-2029

Global Pentavalent Vaccine Supply, Demand and Key Producers, 2023-2029

The global Pentavalent Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).

This report studies the global Pentavalent Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pentavalent Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pentavalent Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Pentavalent Vaccine total production and demand, 2018-2029, (K Units)

Global Pentavalent Vaccine total production value, 2018-2029, (USD Million)

Global Pentavalent Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Pentavalent Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Pentavalent Vaccine domestic production, consumption, key domestic manufacturers and share

Global Pentavalent Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Pentavalent Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Pentavalent Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Pentavalent Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, Crucell and Bio Farma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pentavalent Vaccine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pentavalent Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Pentavalent Vaccine Market, Segmentation by Type
Lyophilized
Liquid

Global Pentavalent Vaccine Market, Segmentation by Application
Retail Pharmacy
Hospital Pharmacy
E-commerce

Companies Profiled:
Serum Institute of India
Panacea Drugs Pvt. Ltd
Shantha Biotechnics
Biological E. Ltd.
Novartis AG
Crucell
Bio Farma

Key Questions Answered

1. How big is the global Pentavalent Vaccine market?

2. What is the demand of the global Pentavalent Vaccine market?

3. What is the year over year growth of the global Pentavalent Vaccine market?

4. What is the production and production value of the global Pentavalent Vaccine market?

5. Who are the key producers in the global Pentavalent Vaccine market?

6. What are the growth factors driving the market demand?